Global Cancer Profiling Market Overview: 2024-2030
Base Year: 2023
Historical Years: 2019-22
Forecast Years: 2024-2030
The Global Cancer Profiling Market size is estimated to grow at a CAGR of around 11.5% during the forecast period, i.e., 2024-30. The Global Cancer Profiling Market is going through significant growth due to multiple drivers like technological advancements and, of course, increasing healthcare needs. The increase in road accidents throughout the country creates a greater demand for X-rays.
Markntel Advisor’s Global Cancer Profiling Market Insights report provides the current and forecast market analysis, individual leading companies' market shares, challenges, Global Cancer Profiling Market drivers, barriers, Global Cancer Profiling Market Trends, and Key Players in Global Cancer Profiling Market.
Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report - This paragraph to be added on Request sample Line and after then add LINK OF SAMPLE
Global Cancer Profiling Market Dynamics: 2024-2030
Global Cancer Profiling Market Challenge:
High Capital Investment in Biomarker Discovery to Hinder the Market Growth – Biomarkers are an integral part of cancer profiling services, as the development of new cancer biomarkers for different cancer indications paves the way for profiling. Pharmaceutical companies like Theseus Pharmaceuticals, Inc., Nektar Therapeutics, Exact Sciences Corporation, etc., have been facing issues like severe side effects, which have led to the termination of their clinical trial studies for biomarkers.
Hence, the high capital investment and associated chances for clinical trial termination have been affecting the adequate development of new biomarkers. Therefore, this has been affecting the reliability of cancer profiling services for new application areas, which has been negatively affecting the market growth.
Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/cancer-profiling-market.html
Global Cancer Profiling Market (2024-30): Segmentation Outlook
The market report has segmented the market into the following categories:
By Type of Cancer
-Breast Cancer - Market Size & Forecast 2019-2030, USD Million
-Colorectal Cancer - Market Size & Forecast 2019-2030, USD Million
-Gynecological Cancer - Market Size & Forecast 2019-2030, USD Million
-Leukemia - Market Size & Forecast 2019-2030, USD Million
-Prostate Cancer - Market Size & Forecast 2019-2030, USD Million
-Lung Cancer - Market Size & Forecast 2019-2030, USD Million
-Others (Pancreatic Cancer, Skin Cancer, etc.) - Market Size & Forecast 2019-2030, USD Million
By Technology
-Next-Generation Sequencing - Market Size & Forecast 2019-2030, USD Million
-Polymerase Chain Reaction - Market Size & Forecast 2019-2030, USD Million
-Mass Spectrometry - Market Size & Forecast 2019-2030, USD Million
-In-Situ Hybridization - Market Size & Forecast 2019-2030, USD Million
-Microarrays Analysis - Market Size & Forecast 2019-2030, USD Million
-Others (Single-Cell Sequencing, etc.) - Market Size & Forecast 2019-2030, USD Million
By Biomarker Type
-Genomic Biomarkers- Market Size & Forecast 2019-2030, USD Million
-Proteomics Biomarkers- Market Size & Forecast 2019-2030, USD Million
-Others (Epigenetic Biomarkers, Metabolomics Biomarkers, etc.)- Market Size & Forecast 2019-2030, USD Million
By Cell Type
-Germline - Market Size & Forecast 2019-2030, USD Million
-Somatic - Market Size & Forecast 2019-2030, USD Million
By Application
-Oncology Research - Market Size & Forecast 2019-2030, USD Million
-Precision Medicine - Market Size & Forecast 2019-2030, USD Million
-Clinical Diagnostics - Market Size & Forecast 2019-2030, USD Million
-Others (Prognosis, Monitoring and Recurrence Detection, etc.) - Market Size & Forecast 2019-2030, USD Million
By End-User
-Hospitals and Clinics - Market Size & Forecast 2019-2030, USD Million
-Research Institutions and Laboratories - Market Size & Forecast 2019-2030, USD Million
-Diagnostic Service Providers - Market Size & Forecast 2019-2030, USD Million
-Pharmaceutical and Biotechnology Companies - Market Size & Forecast 2019-2030, USD Million
By Region
-North America
-South America
-Europe
-Middle East & Africa
-Asia Pacific.
Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
Top Companies Operating in the Global Cancer Profiling Market:
NeoGenomics Laboratories, Eurofins Genomics GmbH, F. Hoffmann-La Roche Ltd (Foundation Medicine) , OncoDNA SA, 10x Genomics, Inc., Caris Life Sciences., Geneseeq Technology Inc., Genetron , Holdings Limited, Laboratory Corporation of America Holdings (LabCorp), Dante Labs Inc., Celemics, Inc., Strand Life Sciences, Myriad Genetics, Inc., QIAGEN GmbH, Tempus Labs, Others.
Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
